DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo

AIM: Targeting the VEGF/VEGF receptor (VEGFR) pathway has proved to be an effective antiangiogenic approach for cancer treatment. Here, we identified 6-((2-((3-acetamidophenyl)amino)pyrimidin-4-yl)oxy)-N-phenyl-1-naphthamide (designated herein as DW10075) as a novel and highly selective inhibitor of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Pharmacol Sin
Main Authors: Li, Meng-yuan, Lv, Yong-cong, Tong, Lin-jiang, Peng, Ting, Qu, Rong, Zhang, Tao, Sun, Yi-ming, Chen, Yi, Wei, Li-xin, Geng, Mei-yu, Duan, Wen-hu, Xie, Hua, Ding, Jian
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4775843/
https://ncbi.nlm.nih.gov/pubmed/26806300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2015.117
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados